Inactive Instrument
Isodiol International Inc Stock Other OTC
Stocks
CA46500L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.79M 2.42M 2.26M 2.07M 266M 3.96M 26.5M 10.4M 133M 10.47M 10.24M 442M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.51M 5.65M 5.29M 4.84M 620M 9.25M 61.87M 24.28M 310M 24.44M 23.91M 1.03B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -90.63% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 2017-05-23 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2018-08-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 2017-05-23 |
| Director/Board Member | - | 2018-08-29 | |
| Director/Board Member | - | 2018-11-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -90.63% | +880.01% | - | - | 128 | |
| -0.41% | -3.91% | -9.42% | -6.39% | 13.4B | |
| -0.74% | -2.52% | +4.97% | +7.27% | 5.09B | |
| -1.00% | -5.52% | -32.31% | -54.85% | 5.04B | |
| -1.09% | -2.22% | +0.31% | -33.98% | 4.02B | |
| -1.15% | -3.73% | -9.85% | -5.22% | 3.66B | |
| +3.32% | +0.59% | +1.16% | +8.14% | 3.7B | |
| -1.46% | -2.46% | -5.61% | +11.28% | 3.43B | |
| -1.47% | -1.22% | -14.85% | -24.25% | 2.41B | |
| -1.25% | -5.49% | -3.94% | +47.93% | 1.85B | |
| Average | -9.59% | -3.02% | -7.73% | -5.56% | 4.73B | |
| Weighted average by Cap. | -0.50% | -3.31% | -8.37% | -8.97% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.64M 11.83M 11.08M 10.14M 1.3B 19.39M 130M 50.88M 649M 51.2M 50.09M 2.16B | 22.25M 15.85M 13.76M 12.88M 11.78M 1.51B 22.54M 151M 59.15M 755M 59.53M 58.23M 2.51B |
| Net income | -36.02M -25.67M -22.28M -20.86M -19.08M -2.45B -36.49M -244M -95.77M -1.22B -96.38M -94.28M -4.07B | -126M -89.73M -77.87M -72.91M -66.7M -8.55B -128M -853M -335M -4.27B -337M -330M -14.21B |
| Net Debt | -15.55M -11.08M -9.62M -9M -8.24M -1.06B -15.75M -105M -41.34M -527M -41.6M -40.7M -1.76B | 5.22M 3.72M 3.23M 3.02M 2.77M 354M 5.29M 35.38M 13.88M 177M 13.97M 13.67M 590M |
Employees
-
Sector
Pharmaceuticals
